The World Health Organization has approved a version of a widely used cholera vaccine that could help address a surge in cases that has depleted the global vaccine stockpile and left poorer countries scrambling to contain epidemics.
WHO authorized the vaccine, made by EuBiologics, which also makes the formulation now used, last week. The new version, called Euvichol-S, is a simplified formula that uses fewer ingredients, is cheaper, and can be made more quickly than the old version.
The vaccine was shown to be help preventing the diarrheal disease in late stage research conducted in Nepal.
WHO’s approval means donor agencies like the vaccines alliance Gavi and UNICEF can now buy it for poorer countries. Leila Pakkala, director of UNICEF’s supply division, said in a statement that the agency will be able to boost supplies by more than 25%.
China's Slow Trains Ensure Smooth Trips During Spring Festival Travel Rush
Youthful Spirits Revitalize Life of Aged Students
Woman's 'Home' a Pillar of Strength for Families with Sick Kids
Hanna and Haley Cavinder say they're returning for last season at Miami
Silk Flowers Help Local Women Gain Employment in Hebei
People Across China Enjoy Spring Festival Holiday
Countdown Starts for China's 14th National Winter Games in Inner Mongolia
District attorney says Memphis police officer may have been killed by friendly fire
People Across China Enjoy Spring Festival Holiday
The Titans go into the NFL draft flexible at No. 7 with lots of needs to fill
Shanghai Weighs Options to Tackle Birthrate Decline